Clinical Trials Browser

INDUSTRY × Advanced Colorectal Carcinoma × Bevacizumab × Clear all

NCT05648006 2024-04-30

First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer

Phase 2 Terminated

Gastrointestinal

Advanced Colorectal Carcinoma